These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 4976866)
21. Development of attenuated rubella virus vaccines in Japan. Shishido A; Ohtawara M Jpn J Med Sci Biol; 1976 Oct; 29(5):227-53. PubMed ID: 827627 [No Abstract] [Full Text] [Related]
22. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells. Mann GF; de Mucha J Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522 [TBL] [Abstract][Full Text] [Related]
23. [What is the present status of the common virus vaccines?]. Regnard J Nouv Presse Med; 1972 Jan; 1(1):33-8. PubMed ID: 5061188 [No Abstract] [Full Text] [Related]
25. Nonhuman primate diploid cells for vaccine production. Petricciani JC Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination. Audet SA; Crim RL; Beeler J Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055 [TBL] [Abstract][Full Text] [Related]
27. Product quality control testing for the oral polio vaccine. Brock B; Kelleher L; Zlotnick B Dev Biol Stand; 1998; 94():217-9. PubMed ID: 9776242 [TBL] [Abstract][Full Text] [Related]
28. The value of potency testing of poliomyelitis and measles vaccines as an integral part of cold chain surveillance. Saraswathy TS; Sinniah M; Lee WS; Lee PC Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):265-8. PubMed ID: 8266228 [TBL] [Abstract][Full Text] [Related]
29. Monitoring vaccines for human oncogenicity. Miller RW Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436 [No Abstract] [Full Text] [Related]
30. Clinical safety issues of measles, mumps and rubella vaccines. Afzal MA; Minor PD; Schild GC Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285 [TBL] [Abstract][Full Text] [Related]
31. Diploid cell lines from subhuman primates as substrates for virus vaccine production. Wallace RE; Vasington PJ; Petricciani JC; Hopps HE; Lorenz DE Prog Immunobiol Stand; 1971; 5():181-6. PubMed ID: 4633958 [No Abstract] [Full Text] [Related]
32. Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. Lerman SJ; Bollinger M; Brunken JM Pediatrics; 1981 Jul; 68(1):18-22. PubMed ID: 7017582 [TBL] [Abstract][Full Text] [Related]
33. Type 4 adenovirus vaccine, live, prepared in human diploid cell system for oral administration. Tint H; Stone JL; Minecci LC; Rubin BA Prog Immunobiol Stand; 1967; 3():113-22. PubMed ID: 5379935 [No Abstract] [Full Text] [Related]
34. The problem of active immunization against measles. Chumakov MP J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):381-8. PubMed ID: 4975393 [No Abstract] [Full Text] [Related]
35. The production and testing of vaccines in human diploid cells, with special reference to rubella. Laurence GD Postgrad Med J; 1972 Jul; 48():Suppl 3:24-9. PubMed ID: 4654267 [No Abstract] [Full Text] [Related]
36. The safety of human diploid cell strains for man: a controlled study of symptoms occurring after the administration of WM-3 living attenuated poliovirus vaccine prepared in the WI-38 human diploid cell strain. Ikić D; Jancikić B; Branica M; Manhalter T Am J Epidemiol; 1968 Mar; 87(2):411-8. PubMed ID: 4296728 [No Abstract] [Full Text] [Related]
37. Development of a diploid cell line from fetal calf lung for virus vaccine production. Mirchamsy H; Bahrami S; Kamali M; Hazrati A; Shafyi A Dev Biol Stand; 1976 Dec 13-15; 37():53-7. PubMed ID: 1036404 [TBL] [Abstract][Full Text] [Related]
38. Measles vaccine in the People's Republic of China. Xiang JZ; Chen ZH Rev Infect Dis; 1983; 5(3):506-10. PubMed ID: 6879006 [TBL] [Abstract][Full Text] [Related]
39. Sensitization of guinea-pigs to measles vaccines. Aprile MA; Kadar D; Wilson S Clin Exp Immunol; 1969 Nov; 5(5):531-9. PubMed ID: 4982816 [TBL] [Abstract][Full Text] [Related]
40. WHO activities towards the three Rs in the development and control of biological products. Milstien J; Grachev V; Padilla A; Griffiths E Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]